BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
Carlyle and SK Capital Complete Acquisition of bluebird bio
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics